Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Spring Bank Pharmaceuticals Inc. (SBPH)

1.19   0.03 (2.59%) 02-21 15:59
Open: 1.13 Pre. Close: 1.16
High: 1.2215 Low: 1.13
Volume: 67,766 Market Cap: 20M
Spring Bank Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of a novel class of therapeutics using a proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.222 - 1.227 1.227 - 1.232
Low: 1.119 - 1.123 1.123 - 1.128
Close: 1.182 - 1.19 1.19 - 1.199

Technical analysis

as of: 2020-02-21 4:33:41 PM
Overall:       
Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 1.98     One year: 2.42
Support: Support1: 1.10    Support2: 0.92
Resistance: Resistance1: 1.70    Resistance2: 2.07
Pivot: 1.18
Moving Average: MA(5): 1.15     MA(20): 1.28
MA(100): 2.57     MA(250): 4.74
MACD: MACD(12,26): -0.20     Signal(9): -0.24
Stochastic oscillator: %K(14,3): 30.76     %D(3): 18.51
RSI: RSI(14): 37.25
52-week: High: 11.00  Low: 1.10  Change(%): -88.3
Average Vol(K): 3-Month: 36211  10-Days: 11876

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
SBPH has closed below upper band by 42.3%. Bollinger Bands are 87.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to SBPH's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2019-12-27
Spring Bank (SBPH) Stops Dosing in HBV Studies, Stock Down
Spring Bank (SBPH) declines as it stops dosing and enrolling patients in phase IIb studies on inarigivir.

2019-10-18
The Daily Biotech Pulse: Intuitive Surgical Earnings, Paratek Pulls Out European Application For Antibiotic, Amgen's Evenity In Europe
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 17) Applied Therapeutics Inc (NASDAQ: APLT ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Celgene Corporation (NASDAQ: CELG ) Kodiak Sciences Inc (NASDAQ: KOD ) The Medicines Company (NASDAQ: MDCO ) Reata Pharmaceuticals Inc (NASDAQ: RETA ) Down In The Dumps (Biotech stocks hitting 52-week lows on Oct. 17) Aileron Therapeutics Inc (NASDAQ: ALRN ) Alpine Immune Sciences Inc (NASDAQ: ALPN ) Diffusion Pharmaceuticals Inc (NASDAQ: DFFN ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Homology Medicines Inc (NASDAQ: FIXX ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA ) Mirum Pharmaceuticals Inc (NASDAQ: MIRM ) Neurometrix Inc (NASDAQ: NURO ) (reacted to its third-quarter results) Puma Biotechnology Inc (NASDAQ: PBYI ) Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL ) Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH ) Theratechnologies Inc (NASDAQ: THTX ) Titan Pharmaceuticals, Inc. (NASDAQ: TTNP ) Stocks In Focus Intuitive Surgical Q3 Tops Expectations Intuitive Surgical, Inc. (NASDAQ: ISRG ) reported third-quarter earnings per share of $3.43 on revenues of $1.13 billion.

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 16.48
Shares Float (M) 11.46
% Held by Insiders 15.00
% Held by Institutions 44.10
Shares Short (K) 27
Shares Short P. Month (K)

Stock Financials

EPS -1.387
Book Value (p.s.) 2.570
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -27.7
Return on Equity (ttm) -42.9
Qtrly Rev. Growth
Gross Profit (p.s.) -1.198
Sales Per Share
EBITDA (p.s.) -1.933
Qtrly Earnings Growth
Operating Cash Flow (M) -27.36
Levered Free Cash Flow (M) -17.16

Stock Valuations

P/E -0.86
P/E Growth Ratio 0.03
P/BV 0.46
P/S
P/CF -0.72

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.